Tracking Cathie Wood: Aggressively increasing positions in NVIDIA and semiconductor infrastructure, while trimming holdings across multiple sectors to rebalance the portfolio

On Monday, August 10, all three major U.S. indices closed slightly lower: the S&P 500 fell 0.06% to 7,753.11, the Nasdaq declined 0.32% to 26,605.36, and the Dow Jones Industrial Average dropped 0.11% to 53,975.98. The market remained in a consolidation phase with light trading volume and no significant macro catalysts driving direction.

Against this backdrop, ARK Invest’s trading activity that day exhibited a clear 'offense-and-defense' strategy—aggressively adding to core positions in technology and life sciences while diversely trimming multiple holdings, reflecting a strategic intent to rebalance positions and optimize capital allocation.

Buying Focus: Concentrating firepower on AI computing power, network infrastructure, and genomics

$NVIDIA (NVDA.US)$ Bought 122,422 shares, the largest single buy of the day. NVIDIA, as the absolute core of AI computing infrastructure, continues to benefit from expanding demand for GPUs driven by large model training and inference workloads. ARK’s significant increase in holdings may further reinforce its strong conviction in NVIDIA’s long-term dominance in AI computing power.

$Cerus (CERS.US)$ Bought 87,357 shares. Cerus specializes in blood safety technologies, and its INTERCEPT Blood System has established a high technological moat in pathogen inactivation, aligning with ARK’s long-term investment thesis in precision medicine and life science innovation.

$Cloudflare (NET.US)$ Bought 58,142 shares. As AI workloads migrate toward the edge, Cloudflare’s position in cybersecurity and edge computing continues to strengthen. ARK’s latest purchase likely reflects its ongoing confidence in companies poised to benefit from next-generation network infrastructure.

$Broadcom (AVGO.US)$ Bought 39,020 shares. Broadcom’s deep investments in AI-customized chips (ASICs) are rapidly materializing, with its TPU/XPU collaborations with leading cloud providers viewed by the market as a key growth driver. ARK’s增持 may serve both to hedge against pure-play compute risk and to enhance its semiconductor infrastructure exposure.

$Intellia Therapeutics (NTLA.US)$ Bought 34,271 shares. NTLA, a pioneer in in vivo CRISPR gene editing, continues to draw attention for its pipeline progress. ARK’s continued accumulation underscores its firm bet on the long-term theme of gene therapies transitioning from clinical trials to commercialization.

$Teradyne (TER.US)$ Bought 25,790 shares. Teradyne is a core supplier of semiconductor test equipment. With the expansion of advanced-node chip capacity and surging demand for AI chips, bottlenecks in testing are intensifying. ARK’s purchase likely reflects its positive outlook on Teradyne’s upside during the upswing of the semiconductor cycle.

$Schrodinger (SDGR.US)$ Bought 1,044 shares. As a representative name in computational biology and AI-driven drug discovery, this small addition appears to be a symbolic rebalancing, maintaining continued exposure to this strategic segment.

Selling activity: Multi-dimensional adjustments, reallocating capital toward higher-conviction opportunities

$10x Genomics (TXG.US)$ Sold 122,590 shares, the largest single sell of the day. 10x Genomics has recently faced fundamental headwinds, with slower-than-expected commercialization of its spatial genomics platform. ARK’s substantial reduction likely reflects a reassessment of its near-to-medium-term earnings realization potential.

$Deere (DE.US)$ Sold 60,458 shares. Deere, a traditional leader in agricultural machinery, falls somewhat outside ARK’s core disruptive innovation framework. This sale appears to be an active portfolio optimization move, redirecting capital toward assets with stronger technology exposure.

$Shopify (SHOP.US)$ Sold 46,101 shares. Shopify's valuation has remained relatively high recently; ARK’s sale may be part of routine portfolio rebalancing to adjust the overall allocation weight of e-commerce infrastructure holdings.

$Iridium Communications (IRDM.US)$ Sold 34,575 shares. The competitive landscape in the satellite communications sector is undergoing significant changes. With continued entry of low-Earth-orbit satellite internet players, ARK may have trimmed its position in IRDM after reassessing the company’s competitive moat.

$Snowflake (SNOW.US)$ Sold 15,830 shares. Competition in the cloud data warehouse space is intensifying, and Snowflake’s positioning as a data platform in the AI era continues to face challenges. This sale likely reflects dynamic reallocation within ARK’s cloud computing segment.

$Palantir (PLTR.US)$ Sold 11,525 shares. Palantir’s valuation remains elevated; ARK’s modest reduction is likely a routine portfolio management move and does not signal a rejection of its growth thesis around AI-driven government and commercial contracts.

$Brera Holdings (SLMT.US)$ Sold 8,512 shares. Given the relatively small size of this holding, the sale likely represents a routine adjustment of a minor position.

$Twist Bioscience (TWST.US)$ Sold 3,418 shares. As a synthetic biology tools company, this minor reduction by ARK appears to be a fine-tuning adjustment within the portfolio, with no significant shift in overall allocation strategy observed.

$Elbit Systems (ESLT.US)$ Sold 1,127 shares. Elbit Systems is a defense-sector holding with limited alignment to ARK’s core innovation framework; this small sale likely continues ARK’s ongoing effort to reduce non-core positions.

Futubull’s [Opportunities Page] now features celebrity portfolio tracking! Choose from multiple celebrity holdings, follow top investors’ moves with one click, precisely target quality stocks, and invest with greater confidence!

238K Views